Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -9.86 % |
3 Month Return | -8.67 % |
1 Year Return | + 31.31 % |
Market Stats | |
Previous Close | ₹189.15 |
Open | ₹192.25 |
Volume | 12.43K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹947.87Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹947.87 Cr |
P/B Ratio | 4.23 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 19.49 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹947.87 Cr | 38.71% | 0.51 | NA | NA | |
NA | ₹6,172.82 Cr | 102.97% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
BUY | ₹4,297.04 Cr | 50.85% | 0.64 | ₹171 Cr | ₹2,528 Cr | |
NA | ₹108.71 Cr | 88.49% | 2.00 | ₹14 Cr | ₹502 Cr | |
NA | ₹143.70 Cr | 27.34% | 0.54 | NA | NA |
Organisation | Anuh Pharma Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Anuh Pharma Ltd
Anuh Pharma Limited reported Q2 earnings with increased sales and net income, but a decline in revenue and earnings per share compared to the previous year. Overall, the results show mixed performance.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 30.05% to 30.06% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.92% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 63.1% return, outperforming this stock by 31.8%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 123.0% return, outperforming this stock by 48.9%
Price Dip
In the last 6 months, Anuh Pharma stock has moved down by -21.7%
FII Holding Down
Foreign Institutions have decreased holdings from 0.03% to 0.02% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 69.92% | 0.00 | |
Foreign Institutions | 0.02% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 30.06% | 0.04 | |
Others | 0% | 0.00 |
Anuh Pharma Ltd’s net profit jumped 8.75% since last year same period to ₹15.04Cr in the Q2 2024-2025. On a quarterly growth basis, Anuh Pharma Ltd has generated 58.15% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Anuh Pharma Ltd has declared dividend of ₹2.50 - translating a dividend yield of 2.38%.
Read More about DividendsBearish
Neutral
Bullish
Anuh Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Anuh Pharma Ltd (506260) share price today is ₹193
Anuh Pharma Ltd is not listed on NSE
Anuh Pharma Ltd is listed on BSE
Today’s traded volume of Anuh Pharma Ltd(506260) is 12.43K.
Today’s market capitalisation of Anuh Pharma Ltd(506260) is ₹947.87Cr.
Anuh Pharma Ltd(506260 | Price |
---|---|
52 Week High | ₹265 |
52 Week Low | ₹140.1 |
Anuh Pharma Ltd(506260) share price is ₹193. It is down -27.17% from its 52 Week High price of ₹265
Anuh Pharma Ltd(506260) share price is ₹193. It is up 37.76% from its 52 Week Low price of ₹140.1
Anuh Pharma Ltd(506260 | Returns |
---|---|
1 Day Returns | 3.85% |
1 Month Returns | -9.86% |
3 Month Returns | -8.67% |
1 Year Returns | 31.31% |